Home > National Drug Code (NDC) > Carbidopa and Levodopa

Carbidopa and Levodopa - 0093-0293-05 - (Carbidopa and Levodopa)

Alphabetical Index


Drug Information of Carbidopa and Levodopa

Product NDC: 0093-0293
Proprietary Name: Carbidopa and Levodopa
Non Proprietary Name: Carbidopa and Levodopa
Active Ingredient(s): 25; 100    mg/1; mg/1 & nbsp;   Carbidopa and Levodopa
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa and Levodopa

Product NDC: 0093-0293
Labeler Name: Teva Pharmaceuticals USA Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA073589
Marketing Category: ANDA
Start Marketing Date: 19930401

Package Information of Carbidopa and Levodopa

Package NDC: 0093-0293-05
Package Description: 500 TABLET in 1 BOTTLE (0093-0293-05)

NDC Information of Carbidopa and Levodopa

NDC Code 0093-0293-05
Proprietary Name Carbidopa and Levodopa
Package Description 500 TABLET in 1 BOTTLE (0093-0293-05)
Product NDC 0093-0293
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carbidopa and Levodopa
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19930401
Marketing Category Name ANDA
Labeler Name Teva Pharmaceuticals USA Inc
Substance Name CARBIDOPA; LEVODOPA
Strength Number 25; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of Carbidopa and Levodopa


General Information